Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)
Acarbose
Bayer Plc
A10BF01
Acarbose
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06010203; GTIN: 5010605048012
85959069 PMR 85959069 (AB/01-C_MU-201709656) Pantone: Black, Orange 021 0 Glucobay ® 50mg tablets ACARBOSE PACKAGE LEAFLET: INFORMATION FOR THE USER 0 Glucobay ® 50mg tablets ACARBOSE Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1 WHAT GLUCOBAY IS AND WHAT IT IS USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE GLUCOBAY 3 HOW TO TAKE GLUCOBAY 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE GLUCOBAY 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 What Glucobay is and what it is used for The active ingredient in this medicine is acarbose. This belongs to a group of medicines called_ glucosidase inhibitors._ GLUCOBAY IS USED TO TREAT NON-INSULIN DEPENDENT DIABETES. It helps to control your blood sugar levels. It works by slowing down the digestion of carbohydrates_ (complex sugars)_ which reduces the abnormally high blood sugar levels in your body after each meal. Glucobay can be used to treat diabetes when a restricted diet alone or a restricted diet plus other sugar-lowering drugs do not work well enough. 2 What you need to know before you take Glucobay Do not take Glucobay: s IF YOU ARE ALLERGIC to acarbose or any of the other ingredients of this medicine (listed in section 6). s IF YOU ARE PREGNANT OR BREAST-FEEDING. s IF YOU HAVE INFLAMMATION OR ULCERATION OF THE BOWEL, for example ulcerative colitis or Crohn’s disease. s IF YOU HAVE AN OBSTRUCTION IN YOUR INTESTINES, or are likely to get this. s IF YOU HAVE A SEVERE LIVER DISORDER . s IF YOU HAVE AN INTESTINE DISEASE where you do not digest or absorb food proper Կարդացեք ամբողջական փաստաթուղթը
OBJECT 1 GLUCOBAY 50MG TABLETS Summary of Product Characteristics Updated 10-Oct-2017 | Bayer plc • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Glucobay 50 mg tablets 2. Qualitative and quantitative composition GLUCOBAY 50 MG TABLETS: 1 tablet contains 50 mg acarbose. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Tablet for oral administration. White to yellow-tinged round, convex tablets of 7 mm diameter and 10 mm radius of curvature with 'G50' on one side and the BAYER-cross on the other side. 4. Clinical particulars 4.1 Therapeutic indications INDICATIONS Glucobay is recommended for the treatment of non-insulin dependent (NIDDM) diabetes mellitus in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents. MODE OF ACTION Glucobay is a competitive inhibitor of intestinal alpha-glucosidases with maximum specific inhibitory activity against sucrase. Under the influence of Glucobay, the digestion of starch and s Կարդացեք ամբողջական փաստաթուղթը